[Severe myelopathy, peripheral neuropathy and optic neuritis appearing during treatment with chloroiodoquin (clioquinol)].
D002493:Central Nervous System Diseases / Q000139:chemically induced*; D002512:Cephalothin / Q000627:therapeutic use; D007464:Clioquinol / Q000009:adverse effects / Q000627:therapeutic use; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009902:Optic Neuritis / Q000139:chemically induced*; D010264:Paraplegia / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
D007464:Clioquinol; D002512:Cephalothin
Myélopathie sévère, neuropathie périphérique et névrite optique survenues au cours d'un traitement par la chloroiodoquine (clioquinol.